Treatment of children under 4 years of age with medulloblastoma and ependymoma in the HIT2000/HIT-REZ 2005 trials: Neuropsychological outcome 5 years after treatment-Reference-Cited by-同舟云学术

Treatment of children under 4 years of age with medulloblastoma and ependymoma in the HIT2000/HIT-REZ 2005 trials: Neuropsychological outcome 5 years after treatment

Published:2020-01-23 Issue:1 Volume:15 Page:e0227693
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Ottensmeier Holger^ORCID,Schlegel Paul G.,Eyrich Matthias^ORCID,Wolff Johannes E.,Juhnke Björn-Ole,von Hoff Katja^ORCID,Frahsek Stefanie,Schmidt Rene,Faldum Andreas,Fleischhack Gudrun^ORCID,von Bueren Andre^ORCID,Friedrich Carsten,Resch Anika,Warmuth-Metz Monika,Krauss Jürgen,Kortmann Rolf D.^ORCID,Bode Udo,Kühl Joachim,Rutkowski Stefan

Funder

Elternverein für Leukämie- und Tumorkranker Kinder Würzburg e.v.

Deutsche Kinderkrebsstiftung

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference49 articles.

1. Treatment of early childhood medulloblastoma by postoperative Chemotherapy and deferred radiotherapy;S Rutkowski;Neuro-Oncology,2009

2. Treatment of early childhood medulloblastoma by postoperative chemotherapy alone;S Rutkowski;The New England journal of medicine,2005

3. Impairment of intellectual functions after surgery and posterior fossa irradiation in children with ependymoma is related to age and neurologic complications;K von Hoff;BMC Cancer,2008

4. Neurodevelopmental impact on children treated for medulloblastoma: a review and proposed conceptual model;SL Palmer;Developmental disabilities research reviews,2008

5. Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma;RK Mulhern;J Clin Oncol,2005

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk factors for domain-specific neurocognitive outcome in pediatric survivors of a brain tumor in the posterior fossa—Results of the HIT 2000 trial;Neuro-Oncology;2024-06-05

2. Radiotherapy for Recurrent Medulloblastoma in Children and Adolescents: Survival after Re-Irradiation and First-Time Irradiation;Cancers;2024-05-22

3. Survivors of infant atypical teratoid/rhabdoid tumors present with severely impaired cognitive functions especially for fluid intelligence and visual processing: data from the German brain tumor studies;Pediatric Blood & Cancer;2024-02-11

4. Intraventricular SHH inhibition proves efficient in SHH medulloblastoma mouse model and prevents systemic side effects;Neuro-Oncology;2023-09-28

5. Questions and answers in the management of children with medulloblastoma over the time. How did we get here? A systematic review;Frontiers in Oncology;2023-06-29